Review




Structured Review

Servicebio Inc antibodies against ki 67
circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) <t>Representative</t> <t>Ki-67</t> IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Antibodies Against Ki 67, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ki+67/pmc13050104-89-5-8?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
antibodies against ki 67 - by Bioz Stars, 2026-08
86/100 stars

Images

1) Product Images from "CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma"

Article Title: CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma

Journal: Non-coding RNA Research

doi: 10.1016/j.ncrna.2026.03.003

circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) Representative Ki-67 IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Figure Legend Snippet: circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) Representative Ki-67 IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.

Techniques Used: In Vivo, Expressing, Immunofluorescence, Immunohistochemistry



Similar Products

86
Servicebio Inc antibodies against ki 67
circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) <t>Representative</t> <t>Ki-67</t> IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Antibodies Against Ki 67, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ki+67/pmc13050104-89-5-8?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
antibodies against ki 67 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

86
Servicebio Inc antibody against ki 67
circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) <t>Representative</t> <t>Ki-67</t> IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Antibody Against Ki 67, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ki+67/pm42249590-127-8-14?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
antibody against ki 67 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

96
Proteintech rabbit polyclonal antibody against ki 67
circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) <t>Representative</t> <t>Ki-67</t> IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.
Rabbit Polyclonal Antibody Against Ki 67, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ki+67/10__1016_slash_j__ajoms__2026__03__013-58-24-30?v=Proteintech
Average 96 stars, based on 1 article reviews
rabbit polyclonal antibody against ki 67 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc antibody against ki67
OptoER relieved vaginal atrophy in ovariectomized (OVX) mice (A) Schematic timeline for the in vivo animal experiment. Adult female mice received a vaginal injection of AAV vectors (AAV-mCherry or AAV-OptoER). One week after viral delivery, mice underwent ovariectomy (OVX) to induce an estrogen-deprived state. Twenty days after OVX, light stimulation was applied, and tissue samples were collected for subsequent analysis. (B) Representative images of H&E-stained vaginal sections from different groups: OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. The results showed improved epithelial thickness and cell density in OVX-OptoER mice. (C) Representative images of PAS-stained sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham groups. Pink areas highlight glycogen-rich layers, indicating differences in the thickness of the cornified layer. (D) Representative images of <t>Ki67-stained</t> vaginal sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. Brown staining indicates proliferating cells. Three mice were examined in each group. Scale bars, 50 μm.
Antibody Against Ki67, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ki+67/pmc12992960-400-8-11?v=Cell+Signaling+Technology+Inc
Average 97 stars, based on 1 article reviews
antibody against ki67 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

86
Servicebio Inc recombinant antibody against ki 67
OptoER relieved vaginal atrophy in ovariectomized (OVX) mice (A) Schematic timeline for the in vivo animal experiment. Adult female mice received a vaginal injection of AAV vectors (AAV-mCherry or AAV-OptoER). One week after viral delivery, mice underwent ovariectomy (OVX) to induce an estrogen-deprived state. Twenty days after OVX, light stimulation was applied, and tissue samples were collected for subsequent analysis. (B) Representative images of H&E-stained vaginal sections from different groups: OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. The results showed improved epithelial thickness and cell density in OVX-OptoER mice. (C) Representative images of PAS-stained sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham groups. Pink areas highlight glycogen-rich layers, indicating differences in the thickness of the cornified layer. (D) Representative images of <t>Ki67-stained</t> vaginal sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. Brown staining indicates proliferating cells. Three mice were examined in each group. Scale bars, 50 μm.
Recombinant Antibody Against Ki 67, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibodies+against+ki+67/pmc13039381-246-26-31?v=Servicebio+Inc
Average 86 stars, based on 1 article reviews
recombinant antibody against ki 67 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) Representative Ki-67 IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.

Journal: Non-coding RNA Research

Article Title: CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma

doi: 10.1016/j.ncrna.2026.03.003

Figure Lengend Snippet: circSMAD4 depletion in macrophages restrains LUAD growth and metastasis in vivo. (A) Schematic of orthotopic lung implantation and experimental metastasis models using LLC cells mixed with BMDMs expressing shNC or sh-circSMAD4. (B) Representative images of orthotopic lung tumors. (C) Tumor weight of orthotopic implants. (D) Overall survival of mice bearing orthotopic tumors. (E) Immunofluorescence showing F4/80 and circSMAD4 signals in tumor tissues. Scale bar, 50 μm. (F, G) Representative Ki-67 IHC staining and quantification in orthotopic tumors. Scale bar, 50 μm. (H) Representative bioluminescence images of lung tumor burden in the metastasis model. (I) Tumor weight in the metastasis model. (J) Overall survival of mice in the metastasis model. (K–M) Representative IHC staining and quantification of E-cadherin and vimentin in tumors. Scale bar, 50 μm. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001; ns, not significant.

Article Snippet: Sections were incubated with primary antibodies against Ki-67 (Servicebio, Cat# GB111499 ), E-cadherin (Proteintech, Cat# 20874-1-AP), and Vimentin (Proteintech, Cat# 10366-1-AP).

Techniques: In Vivo, Expressing, Immunofluorescence, Immunohistochemistry

OptoER relieved vaginal atrophy in ovariectomized (OVX) mice (A) Schematic timeline for the in vivo animal experiment. Adult female mice received a vaginal injection of AAV vectors (AAV-mCherry or AAV-OptoER). One week after viral delivery, mice underwent ovariectomy (OVX) to induce an estrogen-deprived state. Twenty days after OVX, light stimulation was applied, and tissue samples were collected for subsequent analysis. (B) Representative images of H&E-stained vaginal sections from different groups: OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. The results showed improved epithelial thickness and cell density in OVX-OptoER mice. (C) Representative images of PAS-stained sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham groups. Pink areas highlight glycogen-rich layers, indicating differences in the thickness of the cornified layer. (D) Representative images of Ki67-stained vaginal sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. Brown staining indicates proliferating cells. Three mice were examined in each group. Scale bars, 50 μm.

Journal: iScience

Article Title: Optogenetic manipulation of estrogen receptor signaling to improve estrogen deficiency

doi: 10.1016/j.isci.2026.115105

Figure Lengend Snippet: OptoER relieved vaginal atrophy in ovariectomized (OVX) mice (A) Schematic timeline for the in vivo animal experiment. Adult female mice received a vaginal injection of AAV vectors (AAV-mCherry or AAV-OptoER). One week after viral delivery, mice underwent ovariectomy (OVX) to induce an estrogen-deprived state. Twenty days after OVX, light stimulation was applied, and tissue samples were collected for subsequent analysis. (B) Representative images of H&E-stained vaginal sections from different groups: OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. The results showed improved epithelial thickness and cell density in OVX-OptoER mice. (C) Representative images of PAS-stained sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham groups. Pink areas highlight glycogen-rich layers, indicating differences in the thickness of the cornified layer. (D) Representative images of Ki67-stained vaginal sections from OVX-Ctrl, OVX-OptoER, OVX-E2, and Sham mice. Brown staining indicates proliferating cells. Three mice were examined in each group. Scale bars, 50 μm.

Article Snippet: The sections were then incubated with a primary antibody against Ki67 (CST #12202), followed by a biotinylated secondary antibody and streptavidin-HRP complex.

Techniques: In Vivo, Injection, Staining